|
Volumn 33, Issue 1, 2005, Pages 80-82
|
Clinical outcome of long-term lamivudine treated chronic HBV infected and HIV/HBV coinfected patients [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADEFOVIR;
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
TENOFOVIR;
ADULT;
ANTIBIOTIC RESISTANCE;
CHI SQUARE DISTRIBUTION;
CHRONIC HEPATITIS;
COMORBIDITY;
CONTROLLED STUDY;
DRUG THERAPY;
FEMALE;
FOLLOW UP;
HEPATITIS B;
HEPATITIS B VIRUS;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HISTOPATHOLOGY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
LIVER BIOPSY;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
OUTCOMES RESEARCH;
PARAMETRIC TEST;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SEROCONVERSION;
STATISTICAL ANALYSIS;
STATISTICAL SIGNIFICANCE;
VIRUS LOAD;
VIRUS MUTANT;
|
EID: 15944381862
PISSN: 13866532
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jcv.2004.12.002 Document Type: Letter |
Times cited : (2)
|
References (5)
|